Legacy Pharmaceutical Packaging – Recall of losartan
March 15 2019 - Legacy Pharmaceutical Packaging announced two voluntary, consumer-level recalls (Torrent, Camber) of some lots of losartan tablets due to the detection of trace amounts of an unexpected impurity, N-Nitroso N-Methyl 4-amino butyric acid (NMBA), a possible process impurity or contaminant in an active pharmaceutical ingredient, manufactured by Hetero Labs Limited.
Top